Multipronged gene therapy restores walking in mice after complete spinal cord injury

When the spinal cords of mice and humans are partially damaged, the initial paralysis is followed by the extensive, spontaneous recovery of motor function.

WHO report highlights surge in TB cases and deaths in 2023

The highest number of tuberculosis (TB) cases since global monitoring began were recorded in 2023, according to a report published by the World Health Organization

November 6, 2024

European regulators consider appeal over Amylyx ALS drug

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest

October 11, 2023

Sutro strengthens its immuno-oncology pipeline with two new ADCs – Pharmaceutical Technology

Sutro generated $772m in partnership payments as of 30 June 2023. Image Credit: Plufflyman / Shutterstock. Sutro Biopharma plans to submit investigational new drug (IND)

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.